Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Mutant p53 as an Antigen in Cancer Immunotherapy


Journal article


Navid Sobhani, Alberto D'Angelo, Xu Wang, Ken H Young, Daniele Generali, Yong Li
International Journal of Molecular Science, vol. 21(11), 2020, p. 4087


Cite

Cite

APA   Click to copy
Sobhani, N., D'Angelo, A., Wang, X., Young, K. H., Generali, D., & Li, Y. (2020). Mutant p53 as an Antigen in Cancer Immunotherapy. International Journal of Molecular Science, 21(11), 4087. https://doi.org/10.3390/ijms21114087


Chicago/Turabian   Click to copy
Sobhani, Navid, Alberto D'Angelo, Xu Wang, Ken H Young, Daniele Generali, and Yong Li. “Mutant p53 as an Antigen in Cancer Immunotherapy.” International Journal of Molecular Science 21, no. 11 (2020): 4087.


MLA   Click to copy
Sobhani, Navid, et al. “Mutant p53 as an Antigen in Cancer Immunotherapy.” International Journal of Molecular Science, vol. 21, no. 11, 2020, p. 4087, doi:10.3390/ijms21114087.


BibTeX   Click to copy

@article{navid2020a,
  title = {Mutant p53 as an Antigen in Cancer Immunotherapy},
  year = {2020},
  issue = {11},
  journal = {International Journal of Molecular Science},
  pages = {4087},
  volume = {21},
  doi = {10.3390/ijms21114087},
  author = {Sobhani, Navid and D'Angelo, Alberto and Wang, Xu and Young, Ken H and Generali, Daniele and Li, Yong}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in